Skip to main content

Vaccine

Schaffner Report: COVID-19 Vaccines for Young Children

The US has taken another big step forward in responding to the COVID-19 pandemic with vaccines now approved for children age 6 months and older. Many parents and healthcare professionals (HCPs) have been eagerly anticipating this development, while others may still be on the fence. In this final episode of the Schaffner Report,¬†William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID) talks with NFID Executive Director and CEO Marla Dalton, CAE, about the implications for parents and HCPs alike …

Protecting Adults Against Pneumococcal Disease

In the US, pneumococcal pneumonia causes approximately 150,000 hospitalizations each year, and about 1 in 20 individuals who get pneumococcal pneumonia will die. Despite the availability of safe and effective vaccines, many US adults remain unvaccinated. NFID has developed new tools and resources to raise awareness about the importance of prevention through vaccination …

ID News Round-Up: COVID-19 Prevention and Treatment

US health officials are predicting a new wave of COVID-19 infections in the fall, and the Food and Drug Administration (FDA) has issued new guidance on COVID-19 vaccines and treatments. Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 prevention and treatment …

Many US Adults Are Not Fully Protected against Hepatitis B

April 30 is National Adult Hepatitis B Vaccination Awareness Day. As the hepatitis B vaccine recommendation for adults shifts from risk-based to routine, there is an opportunity to increase adult vaccination rates, and education will be a critical part of successfully implementing the new recommendation. Special thanks to Michaela Jackson, MPH, MS, prevention policy manager of the Hepatitis B Foundation for this guest blog post on the importance of preventing hepatitis B in adults …

ID News Round-Up: Additional COVID-19 Boosters

The Food and Drug Administration (FDA) recently authorized a second booster dose of COVID-19 vaccine for adults age 50 years and older and certain individuals who have undergone solid organ transplants or who have other conditions that weaken their immune systems. Soon after, the Centers for Disease Control and Prevention (CDC) updated its guidance to reflect the expanded eligibility. Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 booster doses …

Vaccines Are Not Just for Young Children

CDC recommends vaccinations from birth to adulthood to provide a lifetime of protection. Yet many adolescents are not vaccinated as recommended, leaving them unnecessarily vulnerable. International Adolescent Health Week (March 20-26, 2022) is a perfect time to make sure that pre-teens and teens are up to date on all recommended vaccines …

Short on Time?

Coadministration of COVID-19 vaccines at the same time as other recommended vaccines is safe and convenient. Help spread awareness with these resources …

The Impact of Disparities on Health Outcomes

February is Black History Month, a time to reflect on the past and look toward the future of Black communities. It’s also a time to address persistent health disparities that continue to result in poor health outcomes among communities of color …

ID News Round-Up: COVID-19 Boosters, Tests, Masks, and a New Subvariant

A new subvariant of Omicron has been detected, and public health experts continue to evaluate long-term strategies for curbing the COVID-19 pandemic. Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 and what you should know about the new subvariant, at-home tests, masks, and how to tell the difference between COVID-19 symptoms and other respiratory illnesses …

Schaffner Report: Insights on Updated COVID-19 Guidance

With the Omicron variant on the rise and ongoing changes in public health guidance as the science evolves, it is not surprising that there are many questions about what to do to help stop the spread of COVID-19. In this episode of the Schaffner Report, William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID), talks with NFID Executive Director & CEO Marla Dalton about the latest guidance around COVID-19 vaccine booster doses, masks, quarantine, and testing, as well as the rationale for the recommendations.

Schaffner Report: Widening Circle of Eligibility for COVID-19 Boosters

The widening circle of eligibility for COVID-19 vaccine booster doses has expanded once again and now includes all adults age 18 years and older. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director & CEO Marla Dalton to share important information about the new booster recommendations …